Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

被引:20
作者
Loghavi, Sanam [1 ]
Pemmaraju, Naveen [1 ]
Kanagal-Shamanna, Rashmi [1 ]
Mehrotra, Meenakshi [1 ]
Medeiros, L. Jeffrey [1 ]
Luthra, Raja [1 ]
Lin, Pei [1 ]
Huh, Yang [1 ]
Kantarjian, Hagop M. [2 ]
Cortes, Jorge E. [2 ]
Verstovsek, Srdan [2 ]
Patel, Keyur P. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
CALRETICULIN;
D O I
10.1182/blood-2015-03-632893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3360 / 3363
页数:6
相关论文
共 8 条
[1]   A CALR Mutation Preceding BCR-ABL1 in an Atypical Myeloproliferative Neoplasm [J].
Cabagnols, Xenia ;
Cayuela, Jean-Michel ;
Vainchenker, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07) :688-690
[2]   Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms [J].
Klampfl, Thorsten ;
Gisslinger, Heinz ;
Harutyunyan, Ashot S. ;
Nivarthi, Harini ;
Rumi, Elisa ;
Milosevic, Jelena D. ;
Them, Nicole C. C. ;
Berg, Tiina ;
Gisslinger, Bettina ;
Pietra, Daniela ;
Chen, Doris ;
Vladimer, Gregory I. ;
Bagienski, Klaudia ;
Milanesi, Chiara ;
Casetti, Ilaria Carola ;
Sant'Antonio, Emanuela ;
Ferretti, Virginia ;
Elena, Chiara ;
Schischlik, Fiorella ;
Cleary, Ciara ;
Six, Melanie ;
Schalling, Martin ;
Schoenegger, Andreas ;
Bock, Christoph ;
Malcovati, Luca ;
Pascutto, Cristiana ;
Superti-Furga, Giulio ;
Cazzola, Mario ;
Kralovics, Robert .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2379-2390
[3]   Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2 [J].
Nangalia, J. ;
Massie, C. E. ;
Baxter, E. J. ;
Nice, F. L. ;
Gundem, G. ;
Wedge, D. C. ;
Avezov, E. ;
Li, J. ;
Kollmann, K. ;
Kent, D. G. ;
Aziz, A. ;
Godfrey, A. L. ;
Hinton, J. ;
Martincorena, I. ;
Van Loo, P. ;
Jones, A. V. ;
Guglielmelli, P. ;
Tarpey, P. ;
Harding, H. P. ;
Fitzpatrick, J. D. ;
Goudie, C. T. ;
Ortmann, C. A. ;
Loughran, S. J. ;
Raine, K. ;
Jones, D. R. ;
Butler, A. P. ;
Teague, J. W. ;
O'Meara, S. ;
McLaren, S. ;
Bianchi, M. ;
Silber, Y. ;
Dimitropoulou, D. ;
Bloxham, D. ;
Mudie, L. ;
Maddison, M. ;
Robinson, B. ;
Keohane, C. ;
Maclean, C. ;
Hill, K. ;
Orchard, K. ;
Tauro, S. ;
Du, M-Q ;
Greaves, M. ;
Bowen, D. ;
Huntly, B. J. P. ;
Harrison, C. N. ;
Cross, N. C. P. ;
Ron, D. ;
Vannucchi, A. M. ;
Papaemmanuil, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2391-2405
[4]   JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes [J].
Rumi, Elisa ;
Pietra, Daniela ;
Ferretti, Virginia ;
Klampfl, Thorsten ;
Harutyunyan, Ashot S. ;
Milosevic, Jelena D. ;
Them, Nicole C. C. ;
Berg, Tiina ;
Elena, Chiara ;
Casetti, Ilaria C. ;
Milanesi, Chiara ;
Sant'Antonio, Emanuela ;
Bellini, Marta ;
Fugazza, Elena ;
Renna, Maria C. ;
Boveri, Emanuela ;
Astori, Cesare ;
Pascutto, Cristiana ;
Kralovics, Robert ;
Cazzola, Mario .
BLOOD, 2014, 123 (10) :1544-1551
[5]   Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact [J].
Tefferi, A. ;
Lasho, T. L. ;
Finke, C. ;
Belachew, A. A. ;
Wassie, E. A. ;
Ketterling, R. P. ;
Hanson, C. A. ;
Pardanani, A. .
LEUKEMIA, 2014, 28 (07) :1568-1570
[6]  
Thiele J, 2005, HAEMATOLOGICA, V90, P1128
[7]   Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value [J].
Vannucchi, A. M. ;
Rotunno, G. ;
Bartalucci, N. ;
Raugei, G. ;
Carrai, V. ;
Balliu, M. ;
Mannarelli, C. ;
Pacilli, A. ;
Calabresi, L. ;
Fjerza, R. ;
Pieri, L. ;
Bosi, A. ;
Manfredini, R. ;
Guglielmelli, P. .
LEUKEMIA, 2014, 28 (09) :1811-1818
[8]  
Vardiman J W., 2008, WHO classification of tumors of haematopoietic and lymphoid tissues, V4th, P32